135 related articles for article (PubMed ID: 21787272)
1. KIR molecules: recent patents of interest for the diagnosis and treatment of several autoimmune diseases, chronic inflammation, and B-cell malignancies.
De Re V; Caggiari L; De Zorzi M; Toffoli G
Recent Pat DNA Gene Seq; 2011 Dec; 5(3):169-74. PubMed ID: 21787272
[TBL] [Abstract][Full Text] [Related]
2. The role of KIR positive NK cells in diseases and its importance in clinical intervention.
Dizaji Asl K; Velaei K; Rafat A; Tayefi Nasrabadi H; Movassaghpour AA; Mahdavi M; Nozad Charoudeh H
Int Immunopharmacol; 2021 Mar; 92():107361. PubMed ID: 33429335
[TBL] [Abstract][Full Text] [Related]
3. KIR and KIR ligand polymorphism: a new area for clinical applications?
Falco M; Moretta L; Moretta A; Bottino C
Tissue Antigens; 2013 Dec; 82(6):363-73. PubMed ID: 24498992
[TBL] [Abstract][Full Text] [Related]
4. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.
Parham P; Norman PJ; Abi-Rached L; Guethlein LA
Philos Trans R Soc Lond B Biol Sci; 2012 Mar; 367(1590):800-11. PubMed ID: 22312047
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes.
Salim PH; Jobim M; Jobim LF; Xavier RM
Rev Bras Reumatol; 2011; 51(4):351-6, 362-4. PubMed ID: 21779711
[TBL] [Abstract][Full Text] [Related]
6. The killer-cell immunoglobulin-like receptors of macaques.
Bimber BN; Evans DT
Immunol Rev; 2015 Sep; 267(1):246-58. PubMed ID: 26284482
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing technology a new tool for killer cell immunoglobulin-like receptor allele typing in hematopoietic stem cell transplantation.
Maniangou B; Retière C; Gagne K
Transfus Clin Biol; 2018 Feb; 25(1):87-89. PubMed ID: 29032017
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
9. [Progress in research on genetic polymorphisms and sequence-based typing of KIR genes].
Zhen J; Yu Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):867-870. PubMed ID: 27984624
[TBL] [Abstract][Full Text] [Related]
10. Significance of KIR like natural killer cell receptors in autoimmune disorders.
Agrawal S; Prakash S
Clin Immunol; 2020 Jul; 216():108449. PubMed ID: 32376502
[TBL] [Abstract][Full Text] [Related]
11. The impact of variation at the KIR gene cluster on human disease.
Carrington M; Martin MP
Curr Top Microbiol Immunol; 2006; 298():225-57. PubMed ID: 16329188
[TBL] [Abstract][Full Text] [Related]
12. Allelic Polymorphisms of
Ureshino H; Shindo T; Kojima H; Kusunoki Y; Miyazaki Y; Tanaka H; Saji H; Kawaguchi A; Kimura S
Cancer Immunol Res; 2018 Jun; 6(6):745-754. PubMed ID: 29695383
[TBL] [Abstract][Full Text] [Related]
13. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract][Full Text] [Related]
14. Co-evolution of MHC class I and variable NK cell receptors in placental mammals.
Guethlein LA; Norman PJ; Hilton HG; Parham P
Immunol Rev; 2015 Sep; 267(1):259-82. PubMed ID: 26284483
[TBL] [Abstract][Full Text] [Related]
15. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
16. Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases.
Aiello A; Candore G; Accardi G; Caruso C; Colomba C; Duro G; Gambino CM; Ligotti ME; Di Bona D
Curr Pharm Des; 2018; 24(26):3113-3122. PubMed ID: 30205795
[TBL] [Abstract][Full Text] [Related]
17. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
18. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
20. Role of natural killer cells for immunotherapy in chronic myeloid leukemia (Review).
Lee HR; Baek KH
Oncol Rep; 2019 May; 41(5):2625-2635. PubMed ID: 30896812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
